Edwards Lifesciences Revenue to Assets Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 114.67  1.59  1.41%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Revenue to Assets of Edwards Lifesciences Corporation with missing and latest data points interpolated.
Revenue to Assets  10 Years Trend  
Decreasing
Slightly volatile
 Revenue to Assets 
      Timeline 

Edwards Lifesciences Revenue to Assets Over Time

2015-12-31  0.61 
2016-12-31  0.66 
2017-12-31  0.67 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  0.77
Geometric Mean  0.76
Coefficient Of Variation  12.06
Mean Deviation  0.08021
Median  0.81
Standard Deviation  0.092421
Sample Variance  0.008542
Range  0.27
R Value (0.79)
Mean Square Error  0.003461
R Squared  0.63
Significance  0.002009
Slope (0.020372)
Total Sum of Squares  0.093958

Currently Trending

AJRD   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 34.4
I   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 6.4
CBAY   
 NCM 
Purchased over 90 shares of
few hours ago ago
Traded for 8.14